REDCap Cloud is Selected as WhoDrug Certified Software Vendor
Uppsala Monitoring Centre has approved REDCap Cloud for Inclusion in their Certified Software Vendor Program for WhoDrug
ENCINITAS, Calif., March 15, 2017 – nPhase, Inc., developer of the most widely used EDC platform for academic, commercial and non-profit organizations, REDCap Cloud EDC, announced today that REDCap Cloud has been approved to be one of a select group of qualified vendors for their Certified Software Vendor Program for handling B/C2 format data. The designation of REDCap Cloud as only one of a few select software vendors in this program continues to demonstrate the commitment of REDCap Cloud to industry standards that will help transform the life science industry by bridging the gap between commercial companies and the academic and non-profit organizations conducting clinical studies.
‘We are pleased and excited about being selected by the Uppsala Monitoring Centre to be part of this prestigious program”, noted Scott Climes, CEO of nPhase. “As we continue to pursue our commitment of advancing innovation and closing the gap between academic, non-profit funded research, and the commercial world, being part of this program with WhoDrug will be of great benefit to our clients.”
REDCap Cloud is designed to transform clinical research for the life science industry by offering a cost-effective eClinical platform that enables Sponsors, CROs, investigators, and research teams to collaborate around the world, and to transform patient care in a faster, better, and more cost-effective manner.
About Uppsala Monitoring Centre
Uppsala Monitoring Centre advances the science of pharmacovigilance and inspires patient safety initiatives all over the world. As an independent, non-profit foundation, we engage stakeholders who share our vision and collaborate to build a global patient safety culture. As a leader in the research and development of new scientific methods, we explore the benefits and risks of medicines to help minimize harm to patients, and offer products and services used by health authorities and life-science companies worldwide. Our unique expertise makes us an organization with the capacity to transform patient safety from an ambition into a reality. For almost 40 years, we have provided scientific leadership and operational support to the WHO Program for International Drug Monitoring, expanding the global pharmacovigilance network to reach more than 95% of the world’s population (www.who-umc.org).
For more information, please visit http://www.who-umc.org
About REDCap Cloud
REDCap has been developed by Vanderbilt University for over a decade and is widely used by academic research centers, major nonprofit organizations, and government agencies around the world to support clinical and translational research. The REDCap Consortium is composed of more than 625,000 users in more than 115 countries and has been used in nearly 500,000 research studies. In early 2016, an enhanced commercial-grade version of REDCap, called REDCap Cloud, was launched to support multicenter studies and regulated clinical studies. REDCap Cloud is the first solution to bridge the requirements of both the academic/NPO researchers and the commercial sponsors with technology, functionality, and a business model for all markets. REDCap Cloud is committed to advancing innovation and closing the gap between academic, non-profit funded research, and the commercial world.
For more information, please visit www.redcapcloud.com